SLC6A3 and Parkinson disease: In iRBD, the finding of group-level SN neuromelanin-associated signal and NODDI parameters comparable to HC is not surprising, given that only five out of 13 participants had reduced striatal DAT availability and only two of these had converted to PD after an interval of 36 months since DAT imaging.